KIR3DL2 and neoplasm: Consistent with the CNV results, the expression of tumor-associated genes, including KIR3DL2, TOX, TWIST1, and GTSF1, upregulated along the CD4+ T-cell trajectory (Figure 4H; Supplementary Figure 4C).